On Monday 20 January, Professor Charlotte Cordonnier spoke at a conference dedicated to raising awareness about stroke. The event was a real success, with strong public participation.

💡 An interactive and engaging conference
Participants were invited to answer questions through digital quizzes and animations, providing valuable insight into their level of knowledge about stroke. This interactive approach helped identify misconceptions and information gaps on this crucial topic.

🎤 Rich and insightful discussions
Professor Cordonnier highlighted recent advances in the management of different types of stroke. The hospital–university research project #TIPITCH was also presented during the session. Exchanges with the audience provided an opportunity to address key questions and share essential information to help improve prevention and the public’s response to stroke.

🙏 Thank you to all participants and organisers for their commitment and interest in this cause. Together, we continue working to improve stroke care and raise public awareness.

“Together, let’s take care of our brains.”

On 20 January 2025, join us in Marcq‑en‑Barœul for a conference designed to help the public better understand stroke and discover recent medical advances in this field.

🎤 Speaker:
Professor Charlotte Cordonnier, Professor of Neurology at CHU Lille, researcher at the Lille Neuroscience & Cognition Centre (CHU Lille | Inserm | Université de Lille), and coordinator of the TIPITCH project, will present the latest progress in stroke research—particularly haemorrhagic stroke—as well as future perspectives to improve patient care.

💡 Why attend?

📍 Venue: Théâtre Colisée Lumières, 55 Rue Montgolfier, Marcq‑en‑Barœul
⏰ Time: 7:00 p.m.

👉 This event is free and open to all. Your presence matters!
https://lnkd.in/gk_phwnp

On Thursday 7 November, the TIPITCH project – Transforming the Diagnosis of Cerebral Haemorrhage had the privilege of taking part in an exceptional evening at the Tours City Hall, dedicated to raising public awareness about stroke. 🧠🙌

Professors Grégoire Boulouis and Marco Pasi from CHRU Tours delivered excellent presentations on the key challenges of stroke prevention, treatment, and patient care, with a particular focus on major research advances made possible through the RHU TIPITCH project. 🩺🔬

One of the most memorable moments of the evening was the moving testimonies of patients, highlighting the importance of rapid and high‑quality care. The presence of patient associations—who provide continuous support to those affected by stroke—added significant value to this impactful event. 💙

A warm congratulations to the organisers for the success of this event, and sincere thanks to everyone involved in raising awareness of this crucial public health issue. Thank you for the warm welcome! 🎉🙏

Discover the contribution of Professor Charlotte Cordonnier, Head of the Vascular Neurology Department at CHU Lille, researcher at the Lille Neuroscience & Cognition Centre (CHU Lille | Inserm | Université de Lille), and lead investigator of the TIPITCH project – Transforming the Prognosis of Intracerebral Haemorrhage, as she speaks about stroke prevention, patient care, and advances in research.

🎬 Video link below ⬇️
https://lnkd.in/gAgGHYcm

In 2024, stroke remains the leading cause of physical disability in adults. Among the different types of stroke, spontaneous intracerebral haemorrhage (ICH)—accounting for 20% of all strokes—affects 3.5 million people worldwide every year. Nearly half of these patients remain dependent, and no significant improvement in prognosis has been observed in recent years.

This is why TIPITCH, a unique consortium of experts in neurology, haematology, neuroradiology and fundamental research, is working to develop innovative solutions by focusing on three key stages of intracerebral haemorrhage:

🩸 Limiting haematoma expansion
🩸 Enhancing haematoma evacuation
🩸 Reducing peri-haematoma oedema

Led by CHU Lille, TIPITCH is the result of an unprecedented collaboration between researchers (Université de Lille, Inserm), clinicians (CHU Lille, CHRU Tours, CHRU Nancy, CHU Toulouse and CHU Limoges), and industry partners (Op2Lysis, Balt Group). This alliance not only enables the development of therapeutic innovations but also rethinks the organisation of the care pathway for patients affected by haemorrhagic stroke.

The involvement of patient associations is a central component of the project, ensuring that their needs and lived experiences are fully integrated into the research strategy. This work is carried out in close collaboration with StrokeLink, the national clinical research network specialising in stroke.

Funded by the French State and operated by the National Research Agency (ANR) under the France 2030 call for projects (ANR‑23‑RHUS0006), with €9.6 million over five years, this ambitious project aims to fundamentally transform the prognosis of this severe form of stroke.